Release Date: 23/04/13 14:48 Summary: ASX Appendix 3B - Options Vesting, Exercise and Cancellation Price Sensitive: No Download Document 336.14KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status